Journal overview

Journal metrics

Published by Medical Journals Sweden from 2024.

Acta Oncologica is an international peer-reviewed journal based in the Nordic countries. The journal welcomes international contributions and offers global reach.

Acta Oncologic a provides the scientific community with a platform for innovative, comprehensive and clinically relevant cancer research. We strive to publish impactful cancer research with potential to influence future oncology and aim to advance high-quality, clinically relevant cancer research across the broad field of oncology.  

Acta Oncologica is owned by the non-for-profit Acta Oncologica Foundation and is the official scientific journal for the Nordic National Oncology Societies and the Nordic Association of Clinical Physics (NACP).

Acta Oncologica provides a forum for the exchange of information on the etiology, prevention, diagnosis and treatment of all cancer types.

The journal welcomes articles in the following emerging areas:

  • Cancer epidemiology
  • Cancer diagnostics, biomarkers and precision medicine
  • Medical oncology, radiotherapy and radiophysics
  • Survivorship, rehabilitation, late side effects and palliative care
  • Clinical trial protocols (in letter format)

Acta Oncologica publishes original research articles, review articles, letters/brief communications and editorial comments.

Acta Oncologica’s editorial team is committed to efficient, rigorous and constructive peer-review and fair evaluations. The journal operates a single-anonymized peer review policy. 

Read full aims and scope

Latest issues

Previous issue

Cover image for Acta Oncologica, Volume 62, Issue 11
Volume 62, Issue 11, 2023

21st Acta Oncologica Symposium—BiGART 2023 - Biology-Guided Adaptive Radiotherapy - Aarhus, Denmark. June 20-21, 2023